MARGARITA GIVENS: Open Payments
NPI 1831337419 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,634 in 116 payments from 25 companies in 2025. Trend: 2023 $2,331 · 2024 $2,186 · 2025 $2,634
Food & beverage: $2,534Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $526 |
| Amgen Inc. | 12 | $264 |
| Novartis Pharmaceuticals Corporation | 17 | $236 |
| Janssen Biotech, Inc. | 8 | $236 |
| Galderma Laboratories, L.P. | 9 | $196 |
| MERZ NORTH AMERICA, INC. | 1 | $149 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| UCB, Inc. | 1 | $125 |
| Incyte Corporation | 5 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $114 |
Products named: SKYRIZI, Otezla, TREMFYA, NEMLUVIO, RINVOQ, Xeomin, DUPIXENT, Bimzelx.
Industry payments across FL — which companies pay providers there.
